Mixed
GLP-1 receptor agonists for obesity treatment cause significant loss of lean body mass (approximately 38% of total weight loss) and muscle mass, increasing the risk of sarcopenia and bone loss, particularly in the absence of structured resistance training and adequate protein intake.
If you are taking a GLP-1 medication for weight loss, expect to lose some muscle along with fat. To protect your strength and metabolism, you must prioritize resistance training (weight lifting or bodyweight exercises) and ensure you are eating enough protein. Without these steps, you risk losing significant muscle mass, which can happen with any rapid weight loss method.
In the STEP 1 trial, of the average 13.6-kg–weight reduction, 8.3 kg (62%) was fat mass and 5.3 kg (38%) was lean body mass (including muscle and other nonfat tissues)... Because muscle mass is about half of lean body mass, this corresponds to ~20% of total weight reduction being muscle loss.
Why this rating
Based on data from landmark randomized controlled trials (STEP 1, SURMOUNT 1) cited in the advisory.
Source
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Dariush Mozaffarian et al. · American Journal of Clinical Nutrition · 2025
DOI 10.1016/j.ajcnut.2025.04.023
More from this paper
- Discontinuation of GLP-1 therapy for obesity leads to significant weight regain (up to two-thirds of lost weight within one year), even when accompanied by conventional nutritional counseling, highlighting the need for long-term lifestyle support.Good
- GLP-1 therapy for obesity increases the risk of nutritional deficiencies (e.g., iron, calcium, vitamins A, D, E, K, B1, B12, C) due to significant reductions in caloric intake and potential GI side effects that impair absorption.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →